
With so much unpredictability around how the incoming Trump administration and the new Republican Congress will replace the ACA, the industry’s representatives have been taking more of a wait and see approach.
“Keep your powder dry,” Greg Crist, executive vice president of public affairs at AdvaMed, says of the approach. AdvaMed for now has a laser-like focus on quickly achieving a major policy goal: permanent repeal of the 2.3% medical device excise tax that was part of the ACA.
Get the full story on our sister site, Medical Design & Outsourcing.